Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125759474 | 12575947 | 4 | F | 20160919 | 20160720 | 20160927 | EXP | CA-TAKEDA-2016MPI006477 | TAKEDA | 82.00 | YR | F | Y | 0.00000 | 20160927 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125759474 | 12575947 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | 1 MG/M2, UNK | U | UNKNOWN | 21602 | 1 | MG/M**2 | INJECTION | |||||
| 125759474 | 12575947 | 2 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | 1 MG/M2, UNK | U | UNKNOWN | 21602 | 1 | MG/M**2 | INJECTION | |||||
| 125759474 | 12575947 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 40 MG/M2, UNK | U | 0 | 40 | MG/M**2 | |||||||
| 125759474 | 12575947 | 4 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 20 MG/M2, UNK | U | 0 | 20 | MG/M**2 | |||||||
| 125759474 | 12575947 | 5 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 40 MG/M2, UNK | U | 0 | 40 | MG/M**2 | |||||||
| 125759474 | 12575947 | 6 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | CAPSULE | QD | |||||
| 125759474 | 12575947 | 7 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 10 MG, QOD | U | 0 | 10 | MG | CAPSULE | QOD | |||||
| 125759474 | 12575947 | 8 | SS | PROCYTOX | CYCLOPHOSPHAMIDE | 1 | Oral | 300 MG/M2, UNK | U | 0 | 300 | MG/M**2 | TABLET | ||||||
| 125759474 | 12575947 | 9 | SS | PROCYTOX | CYCLOPHOSPHAMIDE | 1 | Oral | 300 MG/M2, UNK | U | 0 | 300 | MG/M**2 | TABLET | ||||||
| 125759474 | 12575947 | 10 | C | DIGOXIN. | DIGOXIN | 1 | Unknown | UNK | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125759474 | 12575947 | 1 | Product used for unknown indication |
| 125759474 | 12575947 | 3 | Product used for unknown indication |
| 125759474 | 12575947 | 6 | Plasma cell myeloma |
| 125759474 | 12575947 | 8 | Product used for unknown indication |
| 125759474 | 12575947 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125759474 | 12575947 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125759474 | 12575947 | Bone marrow failure | |
| 125759474 | 12575947 | Thrombocytopenia | |
| 125759474 | 12575947 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |